rs1163073
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000674696.1(NT5C2):c.-25+13039A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.267 in 151,950 control chromosomes in the GnomAD database, including 6,667 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.27 ( 6667 hom., cov: 32)
Consequence
NT5C2
ENST00000674696.1 intron
ENST00000674696.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.127
Publications
30 publications found
Genes affected
NT5C2 (HGNC:8022): (5'-nucleotidase, cytosolic II) This gene encodes a hydrolase that serves as an important role in cellular purine metabolism by acting primarily on inosine 5'-monophosphate and other purine nucleotides. [provided by RefSeq, Oct 2011]
NT5C2 Gene-Disease associations (from GenCC):
- hereditary spastic paraplegia 45Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.477 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NT5C2 | ENST00000674696.1 | c.-25+13039A>G | intron_variant | Intron 1 of 17 | ENSP00000502679.1 | |||||
| NT5C2 | ENST00000675326.1 | c.-169+13977A>G | intron_variant | Intron 1 of 18 | ENSP00000502205.1 | |||||
| NT5C2 | ENST00000676428.1 | c.-118+13977A>G | intron_variant | Intron 1 of 18 | ENSP00000501689.1 |
Frequencies
GnomAD3 genomes AF: 0.267 AC: 40508AN: 151832Hom.: 6663 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
40508
AN:
151832
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.267 AC: 40510AN: 151950Hom.: 6667 Cov.: 32 AF XY: 0.274 AC XY: 20382AN XY: 74270 show subpopulations
GnomAD4 genome
AF:
AC:
40510
AN:
151950
Hom.:
Cov.:
32
AF XY:
AC XY:
20382
AN XY:
74270
show subpopulations
African (AFR)
AF:
AC:
2988
AN:
41470
American (AMR)
AF:
AC:
4521
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
AC:
1086
AN:
3470
East Asian (EAS)
AF:
AC:
2017
AN:
5158
South Asian (SAS)
AF:
AC:
2379
AN:
4816
European-Finnish (FIN)
AF:
AC:
4269
AN:
10508
Middle Eastern (MID)
AF:
AC:
99
AN:
294
European-Non Finnish (NFE)
AF:
AC:
22396
AN:
67960
Other (OTH)
AF:
AC:
584
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1424
2848
4273
5697
7121
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
432
864
1296
1728
2160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1431
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.